Rohan Palekar - Feb 1, 2024 Form 4 Insider Report for 89bio, Inc. (ETNB)

Role: Chief Executive Officer, Director
Signature: /s/ Ryan A. Murr, as attorney-in-fact for Rohan Palekar
Stock symbol: ETNB
Transactions as of: Feb 1, 2024
Transactions value $: -$49,666
Form type: 4
Date filed: 2/5/2024, 08:16 PM
Previous filing: Jan 18, 2024
Next filing: Feb 13, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ETNB	Common Stock	Award	$0	+150K	+43.02%	$0.00	499K	Feb 1, 2024	Direct	F1
transaction	ETNB	Common Stock	Tax liability	-$49.7K	-5.07K	-1.02%	$9.80	494K	Feb 5, 2024	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ETNB	Stock Option (Right to Buy)	Award	$0	+605K		$0.00	605K	Feb 1, 2024	Common Stock	605K	$9.98	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted stock units ("RSUs") that vest in equal semi-annual installments over three years, subject to the Reporting Person's continued service to the Issuer.
F2	These shares were withheld from the vesting of a performance-based RSU award to cover the estimated tax withholding obligation.
F3	This option represents a right to purchase a total of 605,000 shares of the Issuer's Common Stock, one quarter of which will vest on February 1, 2025, with the remaining three quarters vesting in equal quarterly installments over the following three years, subject to the Reporting Person's continued service to the Issuer.